Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)

PHASE4CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

February 28, 2015

Study Completion Date

September 30, 2015

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

insulin glargine

sc injection

DRUG

metformin

oral administration

DRUG

acarbose

oral administration

BEHAVIORAL

lifestyle therapy

diet and exercise

DRUG

insulin glargine

sc injection

DRUG

metformin

oral administration

DRUG

acarbose

oral administration

BEHAVIORAL

lifestyle therapy

diet and exercise

OTHER

Standard glycemic care

as informed by the current clinical practice guidelines

Trial Locations (1)

L8N 3Z5

McMaster University Medical Centre, Diabetes Care and Research Program, Hamilton

All Listed Sponsors
collaborator

Hamilton Health Sciences Corporation

OTHER

lead

Population Health Research Institute

OTHER